ACET Q3 2023 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$52M

Net Income

-$50M

EPS (Diluted)

$-18.56

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$233M

Total Liabilities

$39M

Stockholders' Equity

$195M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$52M	-$23M	-127.4%
Net Income	-$50M	-$22M	-126.8%